- Home
- RGR vs DCTH Comparison
RGR vs DCTH Comparison
Compare RGR & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGR
- DCTH
- Stock Information
- Founded
- RGR 1949
- DCTH 1988
- Country
- RGR United States
- DCTH United States
- Employees
- RGR N/A
- DCTH N/A
- Industry
- RGR Ordnance And Accessories
- DCTH Medical/Dental Instruments
- Sector
- RGR Industrials
- DCTH Health Care
- Exchange
- RGR Nasdaq
- DCTH Nasdaq
- Market Cap
- RGR 627.3M
- DCTH 518.0M
- IPO Year
- RGR N/A
- DCTH N/A
- Fundamental
- Price
- RGR $39.29
- DCTH $11.63
- Analyst Decision
- RGR
- DCTH Strong Buy
- Analyst Count
- RGR 0
- DCTH 4
- Target Price
- RGR N/A
- DCTH $22.75
- AVG Volume (30 Days)
- RGR 141.4K
- DCTH 476.1K
- Earning Date
- RGR 04-30-2025
- DCTH 05-13-2025
- Dividend Yield
- RGR 1.78%
- DCTH N/A
- EPS Growth
- RGR N/A
- DCTH N/A
- EPS
- RGR 1.77
- DCTH N/A
- Revenue
- RGR $535,643,000.00
- DCTH $37,205,000.00
- Revenue This Year
- RGR $4.74
- DCTH $128.78
- Revenue Next Year
- RGR N/A
- DCTH $54.07
- P/E Ratio
- RGR $22.20
- DCTH N/A
- Revenue Growth
- RGR N/A
- DCTH 1701.69
- 52 Week Low
- RGR $34.11
- DCTH $4.26
- 52 Week High
- RGR $47.28
- DCTH $16.97
- Technical
- Relative Strength Index (RSI)
- RGR 54.97
- DCTH 44.80
- Support Level
- RGR $37.29
- DCTH $11.20
- Resistance Level
- RGR $39.45
- DCTH $11.81
- Average True Range (ATR)
- RGR 0.92
- DCTH 0.98
- MACD
- RGR 0.01
- DCTH 0.04
- Stochastic Oscillator
- RGR 87.60
- DCTH 51.25
About RGR Sturm Ruger & Company Inc.
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The Company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.